Physician profile
Deepak P Vivek
NPI 1487646717
$24,508.65
in general payments reported to CMS, 2019-2025
28 companies · $2,599 in 2025
The $2,599 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,020 · 2020: $926 · 2021: $2,279 · 2022: $3,393 · 2023: $6,892 · 2024: $6,401 · 2025: $2,599.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $8,820 · Food and Beverage: $5,712 · Travel and Lodging: $1,360.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $8,820.00 |
| Food and Beverage | $5,711.86 |
| Travel and Lodging | $1,359.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $11,071.18 | 2021-2025 | Corevalve Evolut R, Symplicity G3, Resolute Onyx |
| Abbott Laboratories | $4,122.30 | 2019-2025 | Tendyne, Mitraclip, Navitor |
| Edwards Lifesciences Corporation | $3,048.69 | 2019-2025 | Sapien 3 Ultra Resilia, Pascal, Evoque |
| Boston Scientific Corporation | $1,324.48 | 2019-2024 | Ekosonic, Avvigo Guidance System, Rotapro |
| Penumbra, INC. | $1,184.15 | 2022 | |
| Abiomed | $1,084.89 | 2019-2025 | Impella |
| Cardiovascular Systems INC. | $371.14 | 2019-2023 | Diamondback Coronary |
| Shockwave Medical, INC | $369.46 | 2020-2025 | |
| Biosense Webster, INC. | $240.19 | 2024-2025 | Nuvision Ice Catheter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $237.49 | 2020-2022 | |
| Medtronic Vascular, INC. | $236.59 | 2019-2020 | |
| Heartflow, INC. | $214.07 | 2025 | |
| Silk Road Medical, INC. | $151.52 | 2022 | |
| W. L. Gore & Associates, INC. | $148.74 | 2020 | |
| Cordis US Corp. | $147.54 | 2023 | Mynx Control, Rain Sheath Transradial |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $128.34 | 2020-2021 | |
| Novo Nordisk INC | $124.45 | 2024 | |
| Impulse Dynamics (USA) INC. | $69.21 | 2022 | |
| Cook Medical LLC | $66.67 | 2020 | |
| Philips North America LLC | $32.80 | 2025 | Azurion 7 M20 |
| Amgen INC. | $32.62 | 2022-2024 | Repatha |
| Teleflex LLC | $30.88 | 2025 | Turnpike |
| Pfizer INC. | $24.48 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $19.34 | 2025 | Camzyos |
| Livanova USA, INC. | $14.98 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $12.45 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deepak Vivek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.